Related Experiment Video
Updated: Feb 23, 2026

Direct Detection of the Acetate-forming Activity of the Enzyme Acetate Kinase
Published on: December 19, 2011
Why is Aged Acetylcholinesterase So Difficult to Reactivate?
Daniel M Quinn1, Joseph Topczewski2, Nilanthi Yasapala3
1Department of Chemistry, University of Iowa, Iowa City, IA 52242, USA. daniel-quinn@uiowa.edu.
Organophosphorus agents inhibit acetylcholinesterase. Aging makes the inhibited enzyme unreactive, posing challenges for reactivation therapies targeting organophosphate poisoning.
Area of Science:
- Biochemistry
- Toxicology
- Enzyme kinetics
Background:
- Organophosphorus agents are potent acetylcholinesterase inhibitors.
- Inhibition involves phosphylation of the active site serine, forming a neutral adduct.
- This adduct can undergo aging, forming a refractory anionic adduct.
Purpose of the Study:
- To review the reasons for the unreactivity of the aged acetylcholinesterase adduct.
- To discuss the challenges in reactivating aged acetylcholinesterase.
- To explore evolutionary mechanisms of transition state stabilization in acetylcholinesterase.
Main Methods:
- Review of existing literature on organophosphorus inhibition and acetylcholinesterase aging.
- Analysis of the chemical structures of inhibited and aged adducts.
- Discussion of enzyme catalysis and transition state theory.
Main Results:
- The aged adduct is an anionic phosphyl adduct, analogous to the deacylation transition state.
- This structural similarity makes the aged adduct refractory to nucleophilic reactivation.
- Evolutionary stabilization of the transition state contributes to the difficulty in reactivation.
Conclusions:
- The aged acetylcholinesterase adduct's resistance to reactivation is due to its transition-state analog structure.
- Reactivation strategies face significant hurdles due to enzyme evolution for efficient catalysis.
- Understanding these mechanisms is crucial for developing effective antidotes for organophosphate poisoning.
More Related Videos
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Pharmacokinetics

